SUCROSOMIAL TECHNOLOGY

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds.

CETYLATED FATTY ACIDS

A patented solution designed to enhance joint and muscle mobility, known for its exceptional skin penetration and rapid absorption.

PRODUCTS

PharmaNutra products are designed to provide a safe and effective response to health and well-being requirements at any stage of life.
R&D

We are committed to advancing nutraceutical science by developing effective, high-quality supplements and medical devices.

In our laboratories, we use cutting-edge research models to drive innovation, blending solid scientific methods with a forward-thinking approach to technology and patents. PharmaNutra's research focuses on key health areas, especially addressing nutritional deficiencies in minerals and vitamins, supporting muscle and joint health and enhancing functional and sports nutrition.

MORE
THERAPEUTIC AREAS

Our scientific research

NEWS

Inform, innovate, inspire: putting health first

Stay updated with the latest from PharmaNutra: scientific insights, events, groundbreaking products and updates tailored to support your professional practice.
News & Events

Pfizer invests in PharmaNutra’s Sucrosomial® Technology

Read more
Iron deficiency

Food supplements: What problems can they cause?

Read more
Raw materials

Atura plant origin proteins: Alesco signs the distribution agreement

Read more
Iron deficiency

The importance of iron in pregnancy: benefits for mothers and babies

Read more
News & Events

PharmaNutra wins the No Doping Life 2022 Award

Read more
Minerals and vitamins

Our body’s absorption of magnesium

Read more
Raw materials

SiderAL® r.m. Readers’ Ingredient of the Year at the NutraIngredients Awards

Read more
News & Events

The new Dallara P217 of the Cetilar Villorba Corse team has been unveiled

Read more
Iron deficiency

Lisbon 2018: 6th International Multidisciplinary Congress on Iron Deficiency (IMCID)

Read more
News & Events

New PharmaNutra HQ: laying of the cornerstone and official start of construction

Read more
Raw materials

Alesco: new trade agreement with Trades SA for Spain and Portugal

Read more
Iron deficiency

Iron deficiency, an increasingly female disorder?

Read more
Raw materials

Alesco-PharmaNutra Merger: from July 2024, Alesco will become a business division of the Group

Read more
News & Events

PharmaNutra means high-level sports

Read more
Iron deficiency

Iron deficiency in childhood and adolescents

Read more